Reduced kinase D‑interacting substrate of 220 kDa (Kidins220) in pancreatic cancer promotes EGFR/ERK signalling and disease progression
Cited by 6
Related Papers
MiR-148a deletion protects from bone loss in physiological and estrogen-deficient mice by targeting NRP1
|Cell Death Discovery|2022|20
Chicago sky blue 6B (CSB6B), an allosteric inhibitor of macrophage migration inhibitory factor (MIF), suppresses osteoclastogenesis and promotes osteogenesis through the inhibition of the NF-κB signaling pathway
|Biochemical Pharmacology|2021|17
Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway
|International Journal of Oncology|2022|10
Bromhexine elevates REP2 expression to stimulate secretion from human primary conjunctiva fornix epithelial cells
|FEBS Letters|2019|8
E2F1 inhibits cellular senescence and promotes oxaliplatin resistance in colorectal cancer
|Annals of Translational Medicine|2023|4